Susan YoungFollow @twitterapi
I’m the biomedicine editor for MIT Technology Review. I look for stories where technology stands to improve human health or advance our understanding of the human condition.
I joined MIT Technology Review in March 2012 after a brief stint in the Washington, D.C., news bureau of the scientific journal Nature. Before I ventured to the East Coast, I spent several years in the San Francisco Bay Area as a doctoral student in molecular biology and one whirlwind year in science-writing boot camp in Santa Cruz.
In California, I wrote for the Stanford University press offices, the Multiple Sclerosis Discovery Forum, and the Salinas Californian newspaper. I grew up in a small town in eastern Texas, surrounded by bird song, rolling cattle fields, and lanky pine trees. When I’m not exploring health tech, you will probably find me cooking or giggling over an exceptional LOLcat.
Susan Young's Stories
Self-trackers are turning their attention to the microbial menageries found on, and in, the human body.
Amgen places a $415 million bet that human genetics will boost drug discovery.
DNA sequencing is the most cost-effective way to screen for drug-resistant strains in prisons, say Stanford researchers.
Cell-free fetal DNA test can be primary screen for aneuoploidy-risk pregnancies, says Ob-Gyn society
The sleek device tallies simple movements like running and biking.
The Internet company will market a test for disease-associated DNA variants.
Cocktails of targeted cancer therapies could push survival beyond just months of additional life.
Electrical stimulation of the visual cortex may one day give image perception to blind people.
A $125,000 hardware-and-software system could help researchers analyze data securely and with less IT support.